The Houston Astros got the worst possible news on Carlos Correa. The All-Star shortstop suffered a complete tear of the peroneus brevis tendon in his left ankle, underwent successful surgery, and will miss the rest of the 2026 season. Recovery is estimated at six to eight months.
The injury was almost cruel in how it happened. Correa was taking swings in the batting cage before the Astros’ game against the Los Angeles Dodgers when he felt the tendon give. No collision. No awkward slide. Just a routine swing that took the heart of Houston’s infield out of the lineup for the rest of the year.
Correa was hitting .279 with a .369 on-base percentage and a .418 slugging percentage across 32 games this season. He was producing exactly what the Astros needed at the plate, providing veteran leadership in the clubhouse, and stabilizing a defense that had been shaky early on. Now he is gone until 2027.
This changes everything for Houston. The Astros were already struggling to find consistent offense, and Correa was one of the few hitters in the lineup who was performing at his expected level. Jose Altuve has had stretches of brilliance, but he cannot carry this team alone. Yordan Alvarez is still finding his rhythm. Kyle Tucker is gone. The lineup is thin.
Defensively, the Astros now have to figure out shortstop in a hurry. Mauricio Dubon can handle the position, but he is not Correa with the glove or the bat. Jeremy Pena is back from his own injury and can play some short, but Houston is going to need to be creative with infield alignments down the stretch.
Joe Espada has a tough job. The Astros are not buried in the AL West, but they are not in a comfortable position either. The Rangers, Mariners, and Athletics are all hanging around, and Houston cannot afford to lose any more ground. Trading from a position of weakness at the deadline is a brutal scenario, and that is now the most likely path forward.
The bigger picture is even more concerning. Correa has a long history of nagging injuries. He had to take a different contract path in free agency because medical reviews flagged his back. He has battled plantar fasciitis. Now this. At 31, the question becomes whether his body can hold up for the duration of his current contract.
For now, the focus is recovery. The surgery was successful. The Astros medical staff is one of the best in baseball. Correa will rehab in Houston and be back for spring training in 2027, but six to eight months on a tendon injury in the lower leg is no joke. There is no rushing this kind of healing.
The trade deadline becomes interesting. Do the Astros buy or sell? If they fall further back in the division, Dana Brown might be forced to listen on guys like Framber Valdez and Ryan Pressly. Houston has been a championship-or-bust franchise for the better part of a decade. Selling pieces for prospects would be a major philosophical shift.
The competitive window is closing fast. Justin Verlander is 43. Altuve is 35. Alvarez is in his prime but cannot do it alone. Without Correa, the Astros have to find another gear from somewhere, and there are no obvious answers on the roster.
This is the kind of injury that defines a season. Houston’s championship hopes for 2026 just took a massive hit, and the road forward looks a lot harder than it did 48 hours ago.
A longtime sports reporter, Carlos Garcia has written about some of the biggest and most notable athletic events of the last 5 years. He has been credentialed to cover MLS, NBA and MLB games all over the United States. His work has been published on Fox Sports, Bleacher Report, AOL and the Washington Post.
